Michel Hessmann won’t face criminal charges amid doping case

Freiburg Public Prosecutor’s Office has dropped its investigation into the 22-year-old due to a lack of evidence

Clock07:58, Monday 29th January 2024
Hessmann hasn't raced since the 2023 Giro d'Italia

© GCN

Hessmann hasn't raced since the 2023 Giro d'Italia

Michel Hessmann won't face criminal charges amid his ongoing doping case after the Freiburg Public Prosecutor's Office dropped its investigation into him, according to WielerFlits.

The young German could still face a suspension from cycling as NADA's (National Anti Doping Agency of Germany) investigation into him is still ongoing.

The 22-year-old, who rides for Visma-Lease a Bike, tested positive for a diuretic medicine on June 14 in an out-of-competition test, a result that was backed up by his B sample, and the German Prosecution Office launched an investigation into the athlete soon after.

He was subsequently suspended by Visma-Lease a Bike (then Jumbo-Visma), and also faced the prospect of a ban from competition, on top of a criminal conviction if the Prosecution Office’s investigation found any wrongdoing.

However, the threat of a criminal prosecution has now ended with the decision to halt the investigation made, according to WielerFlits, because “there is no or insufficient suspicion of a criminal offence”.

Doping has been a criminal offence in Germany since 2015 and, as a resident of the country, Hessmann could have been liable for charges. If found guilty, the crime carries a maximum three-year prison sentence, although no athletes have yet been imprisoned for any length of time for the offence. Instead, a fine is a more common punishment.

As a part of the investigation, which started in the summer of 2023 after he returned the positive test, Hessmann’s premises were searched and electronic items were taken for analysis.

Despite the decision to end the criminal investigation, the prospect of a suspension from racing still looms as NADA (National Anti Doping Agency of Germany) is yet to reveal its decision. After the return of his positive B sample, the German faces charges of having administered a so-far unnamed diuretic medicine which carries a maximum suspension of four years.

While he awaits the decision, the German remains suspended by Visma-Lease a Bike, having last ridden for them at the 2023 Giro d’Italia.

Related Content

Link to Giro d’Italia stage 14 preview: Ganna favourite as GC riders clash in key time trial
Tadej Pogačar and Filippo Ganna will be protagonists in the stage 14 time trial

Giro d’Italia stage 14 preview: Ganna favourite as GC riders clash in key time trial

Filippo Ganna, Tadej Pogačar and Ben O’Connor give their thoughts on the 31km test to Lake Garda, which comes before the race’s queen stage

Clock
Link to Giro d’Italia: Tadej Pogačar swats away Ineos' crosswind ambush as fan selfies prove more of a challenge
With great power comes great responsibility: Tadej Pogačar is always in demand at the Giro d'Italia

Giro d’Italia: Tadej Pogačar swats away Ineos' crosswind ambush as fan selfies prove more of a challenge

The maglia rosa is sitting pretty at the top of the GC standings ahead of the critical stage 14 time trial

Clock
Link to Wout van Aert gears up for comeback at Tour of Norway 'without any expectations'
Wout van Aert's return to the peloton will be a welcome one

Wout van Aert gears up for comeback at Tour of Norway 'without any expectations'

Visma-Lease a Bike leader to make return to racing in Norway two months after the crash that ruled him out of the Spring Classics and Giro d'Italia

Clock
Link to White jersey Antonio Tiberi impressing in 'dream come true' at debut Giro d'Italia
Antonio Tiberi pulls on the white jersey as best young rider at the Giro d'Italia

White jersey Antonio Tiberi impressing in 'dream come true' at debut Giro d'Italia

Italian hoping to consolidate his overall position as first Grand Tour GC attempt outlives expectations so far

Clock
Subscribe to the GCN Newsletter

Get the latest, most entertaining and best informed news, reviews, challenges, insights, analysis, competitions and offers - straight to your inbox